Curbstone Financial Management Corp Trims Stock Position in Colgate-Palmolive (NYSE:CL)

Curbstone Financial Management Corp cut its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 2.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 14,548 shares of the company’s stock after selling 400 shares during the period. Curbstone Financial Management Corp’s holdings in Colgate-Palmolive were worth $1,121,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of CL. Geode Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 0.6% in the first quarter. Geode Capital Management LLC now owns 17,457,294 shares of the company’s stock worth $1,309,583,000 after acquiring an additional 112,177 shares during the last quarter. Moneta Group Investment Advisors LLC increased its position in shares of Colgate-Palmolive by 90,253.2% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock valued at $1,258,627,000 after acquiring an additional 15,956,771 shares during the last quarter. Morgan Stanley boosted its holdings in Colgate-Palmolive by 41.7% during the 4th quarter. Morgan Stanley now owns 11,370,549 shares of the company’s stock valued at $895,886,000 after acquiring an additional 3,345,297 shares during the period. Northern Trust Corp increased its position in shares of Colgate-Palmolive by 0.5% during the first quarter. Northern Trust Corp now owns 10,470,409 shares of the company’s stock worth $793,971,000 after acquiring an additional 50,040 shares during the period. Finally, Deutsche Bank AG raised its position in Colgate-Palmolive by 6.2% in the 1st quarter. Deutsche Bank AG now owns 8,485,041 shares of the company’s stock valued at $637,651,000 after purchasing an additional 493,252 shares in the last quarter. 78.36% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Monday. Royal Bank of Canada reiterated a “sector perform” rating and set a $83.00 target price on shares of Colgate-Palmolive in a research note on Monday, July 31st. Barclays lifted their price target on Colgate-Palmolive from $77.00 to $81.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 1st. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Colgate-Palmolive from $88.00 to $91.00 and gave the company a “buy” rating in a report on Monday, July 31st. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $85.33.

Get Our Latest Research Report on Colgate-Palmolive

Insider Transactions at Colgate-Palmolive

In related news, CEO Noel R. Wallace sold 48,627 shares of Colgate-Palmolive stock in a transaction on Monday, September 11th. The shares were sold at an average price of $73.37, for a total value of $3,567,762.99. Following the transaction, the chief executive officer now directly owns 246,969 shares in the company, valued at approximately $18,120,115.53. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, insider John W. Kooyman sold 21,677 shares of the stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $77.69, for a total transaction of $1,684,086.13. Following the completion of the transaction, the insider now directly owns 6,384 shares of the company’s stock, valued at approximately $495,972.96. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Noel R. Wallace sold 48,627 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $73.37, for a total value of $3,567,762.99. Following the completion of the sale, the chief executive officer now directly owns 246,969 shares of the company’s stock, valued at $18,120,115.53. The disclosure for this sale can be found here. Insiders sold 105,501 shares of company stock worth $7,838,332 over the last 90 days. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded up $0.12 during midday trading on Thursday, hitting $72.95. 973,398 shares of the company’s stock were exchanged, compared to its average volume of 4,671,004. The company has a debt-to-equity ratio of 28.43, a quick ratio of 0.73 and a current ratio of 1.17. The stock has a market cap of $60.31 billion, a price-to-earnings ratio of 40.47, a price-to-earnings-growth ratio of 3.13 and a beta of 0.50. Colgate-Palmolive has a 12-month low of $67.84 and a 12-month high of $82.09. The firm’s 50 day simple moving average is $75.26 and its 200 day simple moving average is $75.85.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings results on Friday, July 28th. The company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.02. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 8.02%. The firm had revenue of $4.82 billion for the quarter, compared to analyst estimates of $4.70 billion. During the same quarter last year, the company posted $0.72 earnings per share. The business’s revenue was up 7.5% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive will post 3.17 EPS for the current year.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.